Why is Shree Pacetronix falling/rising?

Nov 22 2025 12:35 AM IST
share
Share Via
As of 21 Nov, Shree Pacetronix Ltd experienced a decline in its share price, falling by 1.98% to ₹256.80. This short-term dip contrasts with the company’s robust long-term returns and solid financial fundamentals, reflecting a nuanced market response amid recent trading dynamics.




Short-Term Price Movement and Market Context


On 21-Nov, Shree Pacetronix’s shares opened and traded steadily at ₹256.80 but closed lower by ₹5.20, reflecting a 1.98% decrease. This decline is part of a broader short-term downtrend, with the stock losing 4.38% over the past three days. In contrast, the benchmark Sensex gained 0.79% over the last week, highlighting the stock’s underperformance relative to the broader market. Furthermore, the stock underperformed its sector by 1.43% on the day, signalling sector-specific or stock-specific pressures.


Technical indicators reveal that while the stock remains above its 50-day, 100-day, and 200-day moving averages, it is trading below its 5-day and 20-day averages. This suggests some recent selling pressure or profit-taking by short-term traders, despite the underlying strength indicated by longer-term averages. Notably, investor participation has increased, with delivery volumes rising by 15.43% on 20 Nov compared to the five-day average, indicating heightened trading interest amid the price decline.



Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!



  • - Long-term growth stock

  • - Multi-quarter performance

  • - Sustainable gains ahead



Invest for the Long Haul →



Strong Long-Term Performance and Financial Health


Despite the recent dip, Shree Pacetronix has demonstrated exceptional long-term returns. Over the past year, the stock has surged by 107.10%, vastly outperforming the Sensex’s 10.47% gain. Year-to-date, the stock is up 105.44%, compared to the benchmark’s 9.08%. Even over three years, the company’s stock has appreciated by 76.13%, nearly doubling the Sensex’s 39.39% rise. This market-beating performance underscores the company’s sustained growth trajectory and investor confidence.


Fundamentally, the company exhibits strong management efficiency, reflected in a high Return on Capital Employed (ROCE) of 22.02%. Its ability to service debt is robust, with a low Debt to EBITDA ratio of 0.87 times, indicating prudent financial leverage. Operating profit has grown at an impressive annual rate of 38.41%, signalling healthy business expansion. The company’s recent quarterly results for September 2025 were positive, with net sales reaching a record ₹6.59 crores and PBDIT hitting ₹2.01 crores, both the highest recorded. Additionally, cash and cash equivalents stood at ₹11.90 crores, the highest half-year figure, providing a strong liquidity cushion.


Valuation metrics also support the stock’s appeal. With a ROCE of 18 and an enterprise value to capital employed ratio of 5.3, Shree Pacetronix trades at a discount relative to its peers’ historical averages. This suggests the stock remains fairly valued, if not undervalued, despite its strong growth and profitability metrics.



Shree Pacetronix or something better? Our SwitchER feature analyzes this Microcap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!



  • - SwitchER analysis complete

  • - Superior alternatives found

  • - Multi-parameter evaluation



See Smarter Alternatives →



Investor Sentiment and Shareholding Pattern


Investor sentiment appears mixed in the short term, as evidenced by the recent price decline and trading volumes. However, the stock’s liquidity remains adequate for sizeable trades, ensuring smooth market operations. The majority of shareholders are non-institutional, which can sometimes lead to more volatile price movements due to retail investor behaviour. Nevertheless, the company’s consistent financial performance and market-beating returns over multiple time horizons provide a solid foundation for investor confidence.


In summary, the recent fall in Shree Pacetronix’s share price on 21-Nov is primarily a short-term correction amid a broader context of strong fundamentals and exceptional long-term gains. The stock’s underperformance relative to the Sensex and its sector over the past week and days reflects transient market dynamics rather than any fundamental weakness. Investors with a long-term perspective may view the current dip as an opportunity, given the company’s robust profitability, healthy balance sheet, and attractive valuation metrics.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News